Co-Diagnostics, Inc.
CODX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $23 | $39 | $79 | $258 |
| - Cash | $3 | $15 | $23 | $89 |
| + Debt | $2 | $3 | $0 | $0 |
| Enterprise Value | $22 | $27 | $57 | $169 |
| Revenue | $4 | $7 | $34 | $98 |
| % Growth | -42.5% | -80.1% | -65% | – |
| Gross Profit | $3 | $3 | $29 | $86 |
| % Margin | 74.5% | 38.6% | 84% | 88.2% |
| EBITDA | -$39 | -$41 | -$10 | $46 |
| % Margin | -988.6% | -608.9% | -30.1% | 47.4% |
| Net Income | -$38 | -$35 | -$14 | $37 |
| % Margin | -961.4% | -518.7% | -41.6% | 37.5% |
| EPS Diluted | -1.24 | -1.2 | -0.45 | 1.23 |
| % Growth | -3.3% | -166.7% | -136.6% | – |
| Operating Cash Flow | -$29 | -$22 | $7 | $41 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$30 | -$23 | $5 | $40 |